Traditional names like BPC-157 were originally created for research classification and have since been widely, and often inconsistently, used across supplements and injectables, leading to confusion about what the product actually contains
Reduced levels of GSH alter the redox state of the cell by decreasing the GSH/GSSG ratio and/or increasing ROS/RNS formation
Major Ingredients Water, Triethylhexanoin, Hydrogenated Poly(C6-14 Olefin), Butylene Glycol, Niacinamide, Methylpropanediol, 1,2-Hexanediol, Phenyl Trimethicone, Diethoxyethyl Succinate, Polyglyceryl-10 Myristate, Borago Officinalis Extract, Centaurea Cyanus Flower Extract, Chamomilla Recutita (Matricaria) Flower/Leaf Extract, Lavandula Angustifolia (Lavender) Flower Water, Hyacinthus Orientalis (Hyacinth) Extract, Salvia Sclarea (Clary) Extract, Ethylhexylglycerin, Hibiscus Esculentus Fruit Extract, Corchorus Olitorius Leaf Extract, Carum Petroselinum (Parsley) Extract, Hexyl Cinnamal, Limonene, Linalool, Fragrance, Hippophae Rhamnoides Oil, Allantoin, Hydrogenated Lecithin, Sodium Gluconate, Glutathione, Adenosine, Cellulose Gum, Melia Azadirachta Leaf Extract, Melia Azadirachta Flower Extract, Curcuma Longa (Turmeric) Root Extract, Ocimum Sanctum Leaf Extract, Corallina Officinalis Extract, Biotin, Biotinoyl Tripeptide-1, Acetyl Hexapeptide-8, Tripeptide-1, Tripeptide-3, Myristoyl Pentapeptide-17, Hexapeptide-9, Gluconolactone, Alpha-Arbutin, Thioctic Acid Ingredients subject to change at manufacturer's discretion
Investigation of the secondary structures by circular-dichroism spectroscopy confirmed -helical contents of approximately 46.5% for all three peptides in the presence of a helicogenic solvent
Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation
